Why am I still holding Medizone?
I first bought MZEI shares a few years ago when a study of the Asepticsure process appeared in the American Journal of Infection Control. The process looked like a game changer in dealing with the increasing problem of treating HAIs. There were competitors out there; but their systems weren't nearly as effective.
To my dismay, I soon realized that Medizone did not have the resources it needed to be an operating company: no cash, no revenues, and no infrastructure to support sales and service. Would you buy a $100,000 machine (or even a $500 printer) from a company with zero track record?
I sold most of my shares but bought (fewer shares) again when patents were granted. The patents made the intellectual property rights worth the gamble. But we still need EPA approval.
There have been company statements implying that their plan is to sell the company. Of course building an operating company and creating sales would greatly increase the eventual sale price, but Medizone just doesn't have the resources to do this.
My best guess is that they already have found a buyer with the sale contingent on EPA approval. That's what I'm betting on now and why I still own shares. Plus I would really love to see Asepticsure used in hospitals.
And of course there would then finally be a shareholder meeting (HOORAY!) because I'm reasonably certain that you can't sell a publicly held company legally without shareholder approval.
Good luck to us all!
